PCR e-Course Hot lines: drugs and devices for STEMI management

BIOSTEMI, MECHANISM-AMI and FUNCOMBO

Discussant: C. Tamburino

Summary

Watch this session to know more about ultrathin-strut vs thin-strut DES in patients with STEMI undergoing percutaneous coronary intervention (BIOSTEMI), RCT between bioresorbable and durable polymer stent by serial OCT assessment (MECHANISM-AMI), and the results of the FUNCOMBO trial.

Presentations available when logged in:

  • Ultrathin-strut vs. thin-strut DES for primary PCI
  • RCT between bioresorbable and durable polymer stent by serial OCT assessment
  • The FUNCOMBO trial
  • My analysis of BIOSTEMI, different polymers and Biofreedom DES for STEMI